FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010190600> ?p ?o ?g. }

• W2010190600 endingPage "3581" @default.
• W2010190600 startingPage "3572" @default.
• W2010190600 abstract "To assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of the CC chemokine receptor CCR1 antagonist MLN3897 in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX).In this phase IIa, proof-of-concept study, patients meeting the American College of Rheumatology (ACR) criteria for RA who had been taking MTX for >or=6 months with evidence of active disease were randomly assigned to receive either 10 mg oral MLN3897 or matching placebo once daily for 12 weeks (days 1-83) while continuing to receive MTX once a week. Clinical assessments, safety monitoring, and sampling for pharmacokinetic and pharmacodynamic analyses were performed throughout the study. The primary efficacy end point was the difference in the percentage of patients meeting the ACR 20% improvement criteria (achieving an ACR20 response) on day 84 in the MLN3897-treated group compared with that in the placebo-treated group.MLN3897 was well tolerated, with no evidence of systemic immunosuppression. In the intent-to-treat population, there was no significant difference in day 84 ACR20 response rates between MLN3897-treated patients and placebo-treated patients (35% versus 33%, respectively; P=0.72). Results were similar for the per-protocol population. Pharmacokinetic analyses demonstrated no interactions between MLN3897 and MTX. MLN3897 was associated with a high degree of CCR1 occupancy (>or=90% on days 28, 56, and 84 in 82% of patients, by macrophage inflammatory protein 1alpha internalization assay).MLN3897 at a concentration of 10 mg once daily had no discernible activity in patients with RA who were also receiving MTX. The results suggest that CCR1 antagonism is unlikely to be a viable strategy for the treatment of RA when used in isolation at the receptor occupancy levels reached in this study." @default.
• W2010190600 created "2016-06-24" @default.
• W2010190600 creator A5002891869 @default.
• W2010190600 creator A5009499028 @default.
• W2010190600 creator A5012564728 @default.
• W2010190600 creator A5021685324 @default.
• W2010190600 creator A5036411840 @default.
• W2010190600 creator A5063240035 @default.
• W2010190600 creator A5074086651 @default.
• W2010190600 creator A5090087871 @default.
• W2010190600 creator A5068413710 @default.
• W2010190600 date "2009-12-01" @default.
• W2010190600 modified "2023-10-14" @default.
• W2010190600 title "MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study" @default.
• W2010190600 cites W1988650452 @default.
• W2010190600 cites W1991191221 @default.
• W2010190600 cites W2000905503 @default.
• W2010190600 cites W2002584410 @default.
• W2010190600 cites W2011986616 @default.
• W2010190600 cites W2012827463 @default.
• W2010190600 cites W2032226212 @default.
• W2010190600 cites W2033299724 @default.
• W2010190600 cites W2033975073 @default.
• W2010190600 cites W2039664649 @default.
• W2010190600 cites W2044684335 @default.
• W2010190600 cites W2044762171 @default.
• W2010190600 cites W2058177171 @default.
• W2010190600 cites W2064200002 @default.
• W2010190600 cites W2075309835 @default.
• W2010190600 cites W2076538283 @default.
• W2010190600 cites W2077799315 @default.
• W2010190600 cites W2081734937 @default.
• W2010190600 cites W2081827620 @default.
• W2010190600 cites W2106597066 @default.
• W2010190600 cites W2107821023 @default.
• W2010190600 cites W2108650270 @default.
• W2010190600 cites W2110177517 @default.
• W2010190600 cites W2116773813 @default.
• W2010190600 cites W2117706704 @default.
• W2010190600 cites W2121718569 @default.
• W2010190600 cites W2134486617 @default.
• W2010190600 cites W2134866739 @default.
• W2010190600 cites W2152348310 @default.
• W2010190600 cites W2156258211 @default.
• W2010190600 cites W2159106700 @default.
• W2010190600 doi "https://doi.org/10.1002/art.24978" @default.
• W2010190600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19950299" @default.
• W2010190600 hasPublicationYear "2009" @default.
• W2010190600 type Work @default.
• W2010190600 sameAs 2010190600 @default.
• W2010190600 citedByCount "74" @default.
• W2010190600 countsByYear W20101906002012 @default.
• W2010190600 countsByYear W20101906002013 @default.
• W2010190600 countsByYear W20101906002014 @default.
• W2010190600 countsByYear W20101906002015 @default.
• W2010190600 countsByYear W20101906002016 @default.
• W2010190600 countsByYear W20101906002017 @default.
• W2010190600 countsByYear W20101906002018 @default.
• W2010190600 countsByYear W20101906002019 @default.
• W2010190600 countsByYear W20101906002020 @default.
• W2010190600 countsByYear W20101906002021 @default.
• W2010190600 countsByYear W20101906002022 @default.
• W2010190600 countsByYear W20101906002023 @default.
• W2010190600 crossrefType "journal-article" @default.
• W2010190600 hasAuthorship W2010190600A5002891869 @default.
• W2010190600 hasAuthorship W2010190600A5009499028 @default.
• W2010190600 hasAuthorship W2010190600A5012564728 @default.
• W2010190600 hasAuthorship W2010190600A5021685324 @default.
• W2010190600 hasAuthorship W2010190600A5036411840 @default.
• W2010190600 hasAuthorship W2010190600A5063240035 @default.
• W2010190600 hasAuthorship W2010190600A5068413710 @default.
• W2010190600 hasAuthorship W2010190600A5074086651 @default.
• W2010190600 hasAuthorship W2010190600A5090087871 @default.
• W2010190600 hasBestOaLocation W20101906001 @default.
• W2010190600 hasConcept C111113717 @default.
• W2010190600 hasConcept C112705442 @default.
• W2010190600 hasConcept C126322002 @default.
• W2010190600 hasConcept C142724271 @default.
• W2010190600 hasConcept C198451711 @default.
• W2010190600 hasConcept C204787440 @default.
• W2010190600 hasConcept C27081682 @default.
• W2010190600 hasConcept C2777575956 @default.
• W2010190600 hasConcept C2781059491 @default.
• W2010190600 hasConcept C2908647359 @default.
• W2010190600 hasConcept C71924100 @default.
• W2010190600 hasConcept C90924648 @default.
• W2010190600 hasConcept C98274493 @default.
• W2010190600 hasConcept C99454951 @default.
• W2010190600 hasConceptScore W2010190600C111113717 @default.
• W2010190600 hasConceptScore W2010190600C112705442 @default.
• W2010190600 hasConceptScore W2010190600C126322002 @default.
• W2010190600 hasConceptScore W2010190600C142724271 @default.
• W2010190600 hasConceptScore W2010190600C198451711 @default.
• W2010190600 hasConceptScore W2010190600C204787440 @default.
• W2010190600 hasConceptScore W2010190600C27081682 @default.
• W2010190600 hasConceptScore W2010190600C2777575956 @default.
• W2010190600 hasConceptScore W2010190600C2781059491 @default.
• W2010190600 hasConceptScore W2010190600C2908647359 @default.

• next